Jiannan Qiu

机构：Nanjing Drum Tower Hospital · ORCID：0000-0002-6736-7224

发表论文 64 篇 · 总被引 1996 次 · h-index 23

代表论文

SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy (2025 · Cell Death and Differentiation · 被引 19)
Astragaloside IV ameliorates cisplatin-induced liver injury by modulating ferroptosis-dependent pathways (2024 · Journal of Ethnopharmacology · 被引 18)
Xiezhuo Tiaozhi formula inhibits macrophage pyroptosis in the non-alcoholic fatty liver disease by targeting the SIRT1 pathway (2024 · Phytomedicine · 被引 17)
Salvianolic acid A attenuates non-alcoholic fatty liver disease by regulating the AMPK-IGFBP1 pathway (2024 · Chemico-Biological Interactions · 被引 15)
SFAs facilitates ceramide’s de novo synthesis via TLR4 and intensifies hepatocyte lipotoxicity (2025 · International Immunopharmacology · 被引 14)
Multi-omics joint analysis: Pachymic acid ameliorated non-alcoholic fatty liver disease by regulating gut microbiota (2025 · Food Research International · 被引 12)